AstraZeneca
British pharmaceutical company
Follow AstraZeneca on Notably News to receive short updates to your email — rarely!
| 2025 | AstraZeneca opened a new cell therapy manufacturing facility in Rockville, Maryland. |
| March 2025 | AstraZeneca announced the acquisition of Belgian biotech company EsoBiotec for up to $1 billion to enhance its cancer treatment capabilities through EsoBiotec's in vivo cell therapy platform. |
| December 2024 | The company announced the appointment of Rene Haas and Birgit Conix as non-executive directors, with Haas to start in January 2025 and Conix in February 2025. |
| July 2024 | National Institute for Health and Care Excellence (Nice) blocked NHS from providing Enhertu, an innovative breast cancer treatment, due to pricing disagreements with AstraZeneca and Daiichi Sankyo. |
| March 2024 | AstraZeneca announced the acquisition of Amolyt Pharma for $1.05 billion, expanding its pharmaceutical portfolio. |
| March 2024 | The company acquired Fusion Pharmaceuticals Inc for $2 billion in cash, further strengthening its market position. |
| February 2024 | AstraZeneca's chief executive faced criticism from corporate governance experts and investors regarding excessive compensation. |
| November 23 2021 | Prince Charles officially opened the Discovery Centre at AstraZeneca's global headquarters in Cambridge Biomedical Campus, a £1 billion facility designed to accommodate over 2,200 scientists across 16 laboratories. |
| 2016 | The Cambridge-Gothenburg flight route ended as a scheduled public service due to insufficient demand, though continued for AstraZeneca employees. |
| March 2 2015 | AstraZeneca established a direct air route between Cambridge and Gothenburg, operated by SUN-AIR for British Airways, with the company reserving 20 of 32 seats to support staff collaboration. |
This contents of the box above is based on material from the Wikipedia article AstraZeneca, which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.